Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | CDC25A | P30304 | 2/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.38 |
| ▸ | PRKCG | P05129 | 1/20 | 0.38 |
| ▸ | PRKCB | P05771 | 1/20 | 0.38 |
| ▸ | PRKCA | P17252 | 1/20 | 0.38 |
| ▸ | PRKCH | P24723 | 1/20 | 0.38 |
| ▸ | PRKCI | P41743 | 1/20 | 0.38 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.38 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.38 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29767766 | 0.90 | AKT1 (0.48) | AKT1LMNACDC25AESR1ADORA3 | |
| SCHEMBL29767784 | 0.90 | AKT1 (0.48) | AKT1LMNACDC25AESR1ADORA3 | |
| SCHEMBL19712780 | 0.90 | AKT1 (0.48) | AKT1LMNACDC25AESR1ADORA3 | |
| SCHEMBL19712742 | 0.90 | AKT1 (0.48) | AKT1LMNACDC25AESR1ADORA3 | |
| SCHEMBL10631640 | 0.90 | AKT1 (0.48) | AKT1LMNACDC25AESR1ADORA3 | |
| SCHEMBL29767767 | 0.90 | AKT1 (0.48) | AKT1LMNACDC25AESR1ADORA3 | |
| Lithium Ion SCHEMBL19712638 | 0.90 | AKT1 (0.48) | AKT1LMNACDC25AESR1ADORA3 | |
| SCHEMBL9163148 | 0.90 | AKT1 (0.48) | AKT1LMNACDC25AESR1ADORA3 | |
| SCHEMBL11705667 | 0.90 | AKT1 (0.48) | AKT1LMNACDC25AESR1ADORA3 | |
| SCHEMBL29767773 | 0.90 | AKT1 (0.48) | AKT1LMNACDC25AESR1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2540761-B1 | CURABLE RESIN COMPOSITION | MITSUBISHI GAS CHEMICAL CO (JP) | 2016-08-31 | — | — | EP | disclosed |
| US-8853346-B2 | Curable resin composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2014-10-07 | — | — | US | disclosed |
| US-20130018168-A1 | CURABLE RESIN COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2013-01-17 | — | — | US | disclosed |
| EP-2540761-A1 | CURABLE RESIN COMPOSITION | Mitsubishi Gas Chemical Company, Inc. (JP) | 2013-01-02 | — | — | EP | disclosed |
| US-20100267980-A1 | CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2010-10-21 | — | — | US | disclosed |
| US-20090118442-A1 | CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2009-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267980-A1 | CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT | ELL, RAD54L, RPP30 | AKT1 2966/4885LMNA 2696/4885CDC25A 3722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.